Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Distreptaza for pelvic pain after laparoscopy for endometriosis
IRCT20091012002576N51Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2024
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in endometriosis comparing Distreptaza with Placebo (2 arms). Primary endpoint: Pelvic pain. Started Sep 2024; status: completed.
02
Drugs
streptokinase + streptodornase
03
Conditions
endometriosis
Beyond the preview
Go deeper on IRCT20091012002576N51.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20091012002576N51.